These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9160036)

  • 1. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
    Price J; Farish S; Taylor H; O'Day J
    Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the periocular botulinum toxin on the ocular surface and anterior chamber: a prospective study in patients with hemifacial spasm and blepharospasm.
    Romero-Caballero MD; Miralles de Imperial-Ollero JA; Sarabia-Marín E; Villegas-Pérez MP
    Int Ophthalmol; 2023 Aug; 43(8):2731-2736. PubMed ID: 37185774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decompression Surgery in Elderly Patients with Hemifacial Spasm Refractory to Botulinum Toxin.
    Tugend M; Ulane CM; Patel K; Sekula RF
    Mov Disord Clin Pract; 2024 Aug; 11(8):966-972. PubMed ID: 38779725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections.
    Yabumoto C; Osaki MH; Osaki T; Gameiro GR; Campos M; Osaki TH
    Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):475-478. PubMed ID: 36928309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinking Parameters Do Not Normalize After Botulinum Toxin Therapy in Blepharospasm and Hemifacial Spasm Patients.
    Gameiro GR; Osaki MH; Yabumoto C; Osaki T; Garcia DM; Belfort R; Cruz AAV; Osaki TH
    J Neuroophthalmol; 2023 Dec; 43(4):563-568. PubMed ID: 37307066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of patients with essential blepharospasm and hemifacial spasm in the two largest ophthalmology reference centers in Brazil.
    Fowler FA; Yabumoto C; Osaki MH; Gameiro GR; Brabo JL; Matayoshi S; Marinho RCRS; Osaki TH
    Arq Bras Oftalmol; 2023; 87(6):e20220160. PubMed ID: 37851740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of nerve innervation distribution of orbicularis oculi muscle for botulinum neurotoxin application using Sihler's method.
    Çiçek F; Çınaroğlu S; Ceranoğlu FG; Küçük E; Zor KR
    Ann Anat; 2024 Jan; 251():152165. PubMed ID: 37804929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective demonstration of eyelid spasm relief with smartphone and custom software in hemifacial spasm patients.
    Gameiro GR; Yabumoto C; Osaki MH; Monteiro LG; Schor P; Osaki TH
    Int Ophthalmol; 2024 Mar; 44(1):144. PubMed ID: 38498055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin.
    Teive HAG; Germiniani FMB; Munhoz RP; Camargo CHF
    Arq Neuropsiquiatr; 2020 Jan; 78(1):58-59. PubMed ID: 32074181
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient-reported outcomes following a break in ophthalmic botulinum toxin therapy during the COVID-19 pandemic.
    Jamison A; Favor M; Malhotra R
    Can J Ophthalmol; 2024 Feb; 59(1):e41-e45. PubMed ID: 36372133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of 0.3% Hyaluronic Acid Eye Drops for Benign Essential Blepharospasm and Hemifacial Spasm with Botulinum Toxin-induced Dry Eye.
    Poonyathalang A; Tiraset N; Rattanathamsakul N
    Plast Reconstr Surg Glob Open; 2024 Aug; 12(8):e6050. PubMed ID: 39139840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of botulinum toxin injection on blink rate in blepharospasm.
    Yazdanpanah G; Yen MT; Pflugfelder SC
    Orbit; 2023 Dec; 42(6):571-578. PubMed ID: 36484152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facial phantom model: a low-cost and safe tool for teaching botulinum toxin application in neurology residencies.
    Alencar E Silva R; Fraiman P; Godeiro Júnior CO
    Arq Neuropsiquiatr; 2024 Jan; 82(1):1-6. PubMed ID: 38286431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Botulinum Neurotoxin in Ophthalmology.
    Başar E; Arıcı C
    Turk J Ophthalmol; 2016 Dec; 46(6):282-290. PubMed ID: 28050326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five decades of the use of botulinum toxin in ophthalmology.
    Leszczynska A; Nowicka D; Pillunat LE; Szepietowski JC
    Indian J Ophthalmol; 2024 Jun; 72(6):789-795. PubMed ID: 38317306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world experience with botulinum toxin A for the treatment of hemifacial spasm: A study of 1138 injections.
    Gutierrez SAS; Yu JRT; Yalung PM; Jamora RDG
    Clin Neurol Neurosurg; 2021 Apr; 205():106632. PubMed ID: 33865214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - A Randomized Pilot Study.
    Silkiss RZ; Koppinger J; Truong T; Gibson D; Tyler C
    Transl Vis Sci Technol; 2023 Aug; 12(8):17. PubMed ID: 37606606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of non-motor symptoms in cervical dystonia, hemifacial spasm, and blepharospasm patients and their correlation with motor symptoms.
    Yilmaz HN; Bilen S
    Neurol Sci; 2023 Nov; 44(11):4077-4086. PubMed ID: 37700177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mental disorders in blepharospasm].
    Tolmacheva VA; Parfenov VA; Ostroumova TM; Saloukhina NI; Nodel MR; Romanov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12):76-82. PubMed ID: 38147386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm.
    Kilic-Berkmen G; Kim H; Chen D; Yeo CI; Dinasarapu AR; Scorr LM; Yeo WH; Peterson DA; Williams H; Ruby A; Mills R; Jinnah HA
    Mov Disord; 2024 Apr; 39(4):738-745. PubMed ID: 38310362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.